FDA Approves First Fecal Microbiota Treatment
The FDA has approved Ferring Pharmaceuticals’ fecal transplant therapy Rebyota for the prevention of recurrence of C. difficile infection (CDI) in individuals that have completed antibiotic treatment for recurrent CDI.
Source: Drug Industry Daily